MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 13.12.2025
Theratechnologies DSO 2011-2025 | THTX
DSO Jährlich Theratechnologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 82.9 | 66.1 | 55.9 | 128 | 24.7 | 43.1 | 50.7 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 128 | 24.7 | 64.5 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aptorum Group Limited
APM
|
20.6 | $ 1.3 | - | $ 7.09 M |  China |
 |
Arbutus Biopharma Corporation
ABUS
|
31.5 | $ 5.01 | 6.26 % | $ 831 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
6.01 | $ 3.26 | 0.31 % | $ 252 M |  USA |
 |
Aptevo Therapeutics
APVO
|
79 | $ 1.06 | -6.19 % | $ 293 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 0.27 | -3.93 % | $ 588 M |  Israel |
 |
Catalyst Biosciences
CBIO
|
3.24 | $ 13.88 | -1.53 % | $ 914 M | USA |
 |
Ascendis Pharma A/S
ASND
|
132 | $ 221.31 | 0.4 % | $ 5 B |  Danmark |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.18 | -2.93 % | $ 7.65 B |  Australia |
 |
Catalyst Pharmaceuticals
CPRX
|
44.2 | $ 24.01 | 1.65 % | $ 2.84 B | USA |
 |
CorMedix
CRMD
|
127 | $ 11.08 | -3.57 % | $ 564 M | USA |
 |
CRISPR Therapeutics AG
CRSP
|
1.1 K | $ 57.6 | 1.62 % | $ 4.86 B |  Schweiz |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | Britain |
 |
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
62.6 | $ 26.23 | 3.8 % | $ 1.27 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
56.5 | $ 10.87 | 0.65 % | $ 1.41 B | USA |
 |
Anika Therapeutics
ANIK
|
77.3 | $ 9.57 | 0.05 % | $ 140 M | USA |
 |
Eton Pharmaceuticals
ETON
|
30.4 | $ 16.36 | -2.07 % | $ 420 M | USA |
 |
Exelixis
EXEL
|
45.1 | $ 41.5 | 1.5 % | $ 12 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | USA |
 |
Axon Enterprise
AXON
|
134 | $ 551.02 | -2.35 % | $ 41.7 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
150 | $ 2.37 | 3.04 % | $ 14.9 M | USA |
 |
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | USA |
 |
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
169 | $ 11.43 | -0.87 % | $ 739 M | USA |
 |
Biogen
BIIB
|
57.9 | $ 173.99 | -0.06 % | $ 25.3 B | USA |
 |
Abeona Therapeutics
ABEO
|
387 | $ 5.13 | -4.38 % | $ 110 M | USA |